Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC935828297;28298;28299 chr2:178711164;178711163;178711162chr2:179575891;179575890;179575889
N2AB904127346;27347;27348 chr2:178711164;178711163;178711162chr2:179575891;179575890;179575889
N2A811424565;24566;24567 chr2:178711164;178711163;178711162chr2:179575891;179575890;179575889
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTC
  • RefSeq wild type template codon: GAG
  • Domain: Ig-79
  • Domain position: 58
  • Structural Position: 138
  • Q(SASA): 0.0591
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/F rs1266271972 -1.461 1.0 None 0.822 0.624 0.750213111841 gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 5.56E-05 None 0 None 0 0 0
L/F rs1266271972 -1.461 1.0 None 0.822 0.624 0.750213111841 gnomAD-4.0.0 1.59111E-06 None None None None N None 0 0 None 0 2.77239E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.8796 likely_pathogenic 0.8718 pathogenic -2.347 Highly Destabilizing 0.999 D 0.771 deleterious None None None None N
L/C 0.8981 likely_pathogenic 0.8517 pathogenic -1.728 Destabilizing 1.0 D 0.855 deleterious None None None None N
L/D 0.9995 likely_pathogenic 0.9995 pathogenic -3.121 Highly Destabilizing 1.0 D 0.913 deleterious None None None None N
L/E 0.9943 likely_pathogenic 0.9947 pathogenic -2.786 Highly Destabilizing 1.0 D 0.885 deleterious None None None None N
L/F 0.5515 ambiguous 0.4664 ambiguous -1.432 Destabilizing 1.0 D 0.822 deleterious None None None None N
L/G 0.9837 likely_pathogenic 0.9807 pathogenic -2.966 Highly Destabilizing 1.0 D 0.874 deleterious None None None None N
L/H 0.9855 likely_pathogenic 0.9857 pathogenic -2.942 Highly Destabilizing 1.0 D 0.892 deleterious None None None None N
L/I 0.154 likely_benign 0.1658 benign -0.479 Destabilizing 0.999 D 0.695 prob.neutral None None None None N
L/K 0.9898 likely_pathogenic 0.9911 pathogenic -1.717 Destabilizing 1.0 D 0.875 deleterious None None None None N
L/M 0.2468 likely_benign 0.225 benign -0.817 Destabilizing 1.0 D 0.806 deleterious None None None None N
L/N 0.9949 likely_pathogenic 0.995 pathogenic -2.483 Highly Destabilizing 1.0 D 0.915 deleterious None None None None N
L/P 0.9978 likely_pathogenic 0.9984 pathogenic -1.094 Destabilizing 1.0 D 0.911 deleterious None None None None N
L/Q 0.9679 likely_pathogenic 0.9714 pathogenic -2.054 Highly Destabilizing 1.0 D 0.909 deleterious None None None None N
L/R 0.9761 likely_pathogenic 0.9777 pathogenic -2.023 Highly Destabilizing 1.0 D 0.895 deleterious None None None None N
L/S 0.986 likely_pathogenic 0.9851 pathogenic -2.99 Highly Destabilizing 1.0 D 0.877 deleterious None None None None N
L/T 0.9474 likely_pathogenic 0.9455 pathogenic -2.475 Highly Destabilizing 1.0 D 0.828 deleterious None None None None N
L/V 0.186 likely_benign 0.1973 benign -1.094 Destabilizing 0.999 D 0.697 prob.neutral None None None None N
L/W 0.9431 likely_pathogenic 0.9377 pathogenic -1.839 Destabilizing 1.0 D 0.869 deleterious None None None None N
L/Y 0.9575 likely_pathogenic 0.9483 pathogenic -1.603 Destabilizing 1.0 D 0.865 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.